It is true, Rajeswari, that ISO 14971:2019 has no examples, and Clauses 1-10 are all requirements for compliance with the standard. Annexes A, B, and C are guidance for implementation. Annex A is especially valuable as it discloses the thinking of the Technical Committee regarding the requirements. And these three annexes do not discuss reduction of severity either.
However, ISO TR 24971:2020 7.1.1 a) Example 2 is an example of reducing "severity of harm". Clause 7 of this often unread or ignored document addresses the confusion in the area of risk control by the users of the standard. The numbered clauses align with the numbered clauses making it easy to find the guidance for specific requirements. There are a number of cross-cutting topics which are presented in the alphabetic annexes which are especially invaluable. I would especially point to Annex H which is written for IVDs, however there are discussions here that can apply to many other products as well. This includes a discussion of those things that under control of the manufacturer, those under control of the user of the device and those under control of the clinician, which is helpful in understanding hazardous situations.
If you don't have ISO TR 24971:2020, get it. And the EN version is identical to the ISO version, so you can use either. You will better understand the requirements of the standard with the numerous examples and discussions. And you can find valuable advice that will reduce you efforts in application of the standard.
Much effort was put into creating this entirely re-written guidance document, there is all new guidance. ISO charged the Technical Committee with reorganizing the guidance for the standard as there was much confusion between the requirements in the standard and the guidance much of which was formerly included in the standard. As a result of these instructions, much of the guidance was moved to ISO TR 24971:2020 second edition, which was originally published as a first edition in 2013 to address confusion that existed following the 2007 edition of ISO 14971. There are 85 pages of invaluable guidance in this document which will help in understanding of implementation of ISO 14971:2019.
------------------------------
Edwin Bills MEd, BSc, ASQ Fellow, CQE, CQA, MCQ/OE, RAC
Principal Consultant
Overland Park KS
United States
elb@edwinbillsconsultant.com------------------------------
Original Message:
Sent: 02-Mar-2023 13:21
From: Rajeswari Devanathan
Subject: Risk Assessment - Reduction in Severity of Harm
ISO 14971 provides general guidance on risk management for medical devices, including risk control measures. The standard states that risk control measures can be used to reduce the severity of harm or the probability of occurrence of harm, or both, depending on the specific risk.
However, the standard does not provide specific instructions or criteria for when risk control measures would likely reduce the probability versus other types of controls that reduce the severity. The choice of risk control measures will depend on the specific device and the risks associated with its use. The standard emphasizes that the choice of risk control measures should be based on a risk assessment that takes into account factors such as the severity of harm, the probability of occurrence, the state of the art, and the intended use of the device.
In general, risk control measures that aim to reduce the probability of occurrence of harm may include design features that reduce the likelihood of user errors or device malfunctions, warning labels or instructions for use that increase user awareness of potential hazards, and regular maintenance or calibration to ensure proper device functioning.
On the other hand, risk control measures that aim to reduce the severity of harm may include physical barriers or protective equipment that limit the extent of injury in the event of an accident, such as impact-resistant shields or airbags in automobiles, or redundant safety features that provide backup systems in case of device failure.
Ultimately, the choice of risk control measures will depend on the specific device, the risks associated with its use, and the intended users and environments in which it will be used.
------------------------------
Raje Devanathan
Amerisource Bergen
TPIreg, Innomar Strategies
Senior Manager - Regulatory Affairs, Medical Devices
rdevanathan@tpireg.com
3470 Superior Court
Oakville ON L6L0C4
Canada
Original Message:
Sent: 23-Feb-2023 15:31
From: Anonymous Member
Subject: Risk Assessment - Reduction in Severity of Harm
This message was posted by a user wishing to remain anonymous
Based on ISO 14971 Risk control measures can reduce the severity of the harm or reduce the probability of occurrence of
the harm, or both.
Are there instructions for when risk control measures would likely reduce the probability Vs other types of controls that reduce the severity?
Thanks!